Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Garrett Motion Inc. | 27,308,160 | reported | 11 May 2021 | tx 1−761,905 |
| RHI Entertainment, Inc. | 4,900,551 | reported | 30 Mar 2009 | tx 2+437,017 |
| FACET BIOTECH CORP | 4,086,307 | reported | 04 Sept 2009 | tx 5−867,532 |
| KERYX BIOPHARMACEUTICALS INC | 0 | reported | 12 Dec 2018 | tx 4+39,582,335−65,374,013 |
| Orexigen Therapeutics, Inc. | 0 | reported | 31 May 2019 | tx 8−123,710,356 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 May 2021 | SALE | Garrett Motion Inc. | 761,905 | — | deriv |
| 31 May 2019 | OTHER | Orexigen Therapeutics, Inc. | 5,000,000 | — | deriv |
| 31 May 2019 | OTHER | Orexigen Therapeutics, Inc. | — | — | deriv |
| 31 May 2019 | OTHER | Orexigen Therapeutics, Inc. | 100,000,000 | — | deriv |
| 12 Dec 2018 | OTHER | KERYX BIOPHARMACEUTICALS INC | 65,374,013 | — | |
| 11 Dec 2018 | GRANT_AWARD | KERYX BIOPHARMACEUTICALS INC | 35,582,335 | 4.63 USD | |
| 11 Dec 2018 | GRANT_AWARD | KERYX BIOPHARMACEUTICALS INC | 4,000,000 | — | |
| 11 Dec 2018 | EXERCISE | KERYX BIOPHARMACEUTICALS INC | — | — | deriv |
| 31 Oct 2018 | SALE | Orexigen Therapeutics, Inc. | 896,339 | 0.01 USD | |
| 29 Oct 2018 | SALE | Orexigen Therapeutics, Inc. | 650,000 | 0.01 USD | |
| 24 Oct 2018 | SALE | Orexigen Therapeutics, Inc. | 28,000 | 0.01 USD | |
| 25 Oct 2018 | SALE | Orexigen Therapeutics, Inc. | 652,500 | 0.01 USD | |
| 13 Apr 2018 | OTHER | Orexigen Therapeutics, Inc. | 16,483,517 | 0.00 USD | deriv |
| 04 Sept 2009 | SALE | FACET BIOTECH CORP | 150,000 | 15.39 USD | |
| 04 Sept 2009 | SALE | FACET BIOTECH CORP | 100,000 | 15.40 USD | |
| 04 Sept 2009 | SALE | FACET BIOTECH CORP | 579,432 | 15.43 USD | |
| 04 Sept 2009 | SALE | FACET BIOTECH CORP | 27,900 | 15.49 USD | |
| 04 Sept 2009 | SALE | FACET BIOTECH CORP | 10,200 | 15.50 USD |